speb/financial-data huggingface dataset:
CG.TO cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -43510000.00
CG.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 1655916000.00
CG.TO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 3886000.00
CG.TO cash_flow (annual, 2024-12-31) — Common Stock Payments: -44053000.00
CG.TO balance_sheet (annual, 2024-12-31) — Construction In Progress: 108310000.00
CG.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 836455000.00
CG.TO balance_sheet (annual, 2024-12-31) — Current Assets: 993062000.00
CG.TO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 6393000.00
CG.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 6393000.00
CG.TO balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 0.00
CG.TO balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 0.00
CG.TO balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 0.00
CG.TO balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 0.00
CG.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 283880000.00
CG.TO balance_sheet (annual, 2024-12-31) — Current Provisions: 5113000.00
CG.TO balance_sheet (quarterly, 2024-12-31) — Current Provisions: 5113000.00
CG.TO cash_flow (annual, 2024-12-31) — Deferred Income Tax: 93663000.00
CG.TO cash_flow (annual, 2024-12-31) — Deferred Tax: 93663000.00
CG.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 130662000.00
CG.TO balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 5208000.00
CG.TO balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 5208000.00
CG.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 216275000.00
CG.TO income_statement (annual, 2024-12-31) — Diluted EPS: 0.35
CG.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 76371000.00
CG.TO balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 42638000.00
CG.TO balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Non Current: 20450000.00
CG.TO balance_sheet (quarterly, 2024-12-31) — Duefrom Related Parties Non Current: 20450000.00
CG.TO income_statement (annual, 2024-12-31) — EBIT: 175147000.00
CG.TO income_statement (annual, 2024-12-31) — EBITDA: 305809000.00
CG.TO balance_sheet (annual, 2024-12-31) — Employee Benefits: 1634000.00
CG.TO cash_flow (annual, 2024-12-31) — End Cash Position: 624673000.00
CG.TO balance_sheet (annual, 2024-12-31) — Financial Assets: 20467000.00
CG.TO balance_sheet (quarterly, 2024-12-31) — Financial Assets: 20467000.00
CG.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -93467000.00
CG.TO balance_sheet (annual, 2024-12-31) — Finished Goods: 81662000.00
CG.TO balance_sheet (quarterly, 2024-12-31) — Finished Goods: 81662000.00
CG.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: 114110000.00
CG.TO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: -63088000.00
CG.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 63088000.00
CG.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 603000.00
CG.TO income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 79000.00
CG.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 44207000.00
CG.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -11195000.00
CG.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 37888000.00
CG.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 2110299000.00
CG.TO income_statement (annual, 2024-12-31) — Gross Profit: 378048000.00
CG.TO balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 625000.00
CG.TO balance_sheet (quarterly, 2024-12-31) — Hedging Assets Current: 625000.00
CG.TO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 193564000.00
CG.TO balance_sheet (annual, 2024-12-31) — Income Tax Payable: 18731000.00
CG.TO income_statement (annual, 2024-12-31) — Interest Expense: 1090000.00
CG.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 1090000.00
CG.TO income_statement (annual, 2024-12-31) — Interest Income: 30054000.00
CG.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 30054000.00
CG.TO balance_sheet (annual, 2024-12-31) — Inventory: 234249000.00
CG.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 1655916000.00
CG.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -193202000.00
CG.TO balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 77002000.00
CG.TO balance_sheet (annual, 2024-12-31) — Investments And Advances: 77002000.00
CG.TO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 3886000.00
CG.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 13713000.00
CG.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 13713000.00
CG.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -9790000.00
CG.TO balance_sheet (annual, 2024-12-31) — Long Term Provisions: 266195000.00
CG.TO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
CG.TO cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
CG.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -40167000.00
CG.TO cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -16940000.00
CG.TO income_statement (annual, 2024-12-31) — Net Income: 80394000.00
CG.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 80394000.00
CG.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 80394000.00
CG.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 80394000.00
CG.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 80394000.00
CG.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 80394000.00
CG.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 80394000.00
CG.TO income_statement (annual, 2024-12-31) — Net Interest Income: 25682000.00
CG.TO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -7349000.00
CG.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -9790000.00
CG.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -9790000.00
CG.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 25682000.00
CG.TO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -2521000.00
CG.TO cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 0.00
CG.TO balance_sheet (annual, 2024-12-31) — Net PPE: 1101536000.00
CG.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -183332000.00
CG.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 1655916000.00
CG.TO balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 30919000.00
CG.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 60133000.00
CG.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 38587000.00
CG.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 20187000.00
CG.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 60133000.00
CG.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 18400000.00
CG.TO balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1634000.00
CG.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: 391475000.00
CG.TO income_statement (annual, 2024-12-31) — Normalized Income: 153210100.00
CG.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 298401000.00
CG.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -80028000.00
CG.TO income_statement (annual, 2024-12-31) — Operating Income: 236289000.00
CG.TO income_statement (annual, 2024-12-31) — Operating Revenue: 1197150000.00
CG.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 210031280.00
CG.TO balance_sheet (annual, 2024-12-31) — Other Current Assets: 554000.00
CG.TO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 20549000.00
CG.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -11195000.00
CG.TO income_statement (annual, 2024-12-31) — Other Gand A: 32685000.00
CG.TO income_statement (annual, 2024-12-31) — Other Income Expense: -87914000.00
CG.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: -19458000.00
CG.TO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 2481000.00
CG.TO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -2248000.00
CG.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: 70991000.00
CG.TO balance_sheet (annual, 2024-12-31) — Other Payable: 146755000.00
CG.TO balance_sheet (quarterly, 2024-12-31) — Other Payable: 146755000.00
CG.TO balance_sheet (annual, 2024-12-31) — Other Properties: 102957000.00
CG.TO balance_sheet (annual, 2024-12-31) — Other Receivables: 2070000.00
CG.TO balance_sheet (quarterly, 2024-12-31) — Other Receivables: 2070000.00
CG.TO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 3130000.00
CG.TO balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 3130000.00
CG.TO income_statement (annual, 2024-12-31) — Other Special Charges: 2521000.00
CG.TO balance_sheet (annual, 2024-12-31) — Payables: 245067000.00
CG.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 245067000.00
CG.TO balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 6758000.00
CG.TO balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 6758000.00
CG.TO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 12152000.00
CG.TO income_statement (annual, 2024-12-31) — Pretax Income: 174057000.00
CG.TO cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
CG.TO cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
CG.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -7349000.00
CG.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -184291000.00
CG.TO balance_sheet (annual, 2024-12-31) — Raw Materials: 152587000.00
CG.TO balance_sheet (quarterly, 2024-12-31) — Raw Materials: 152587000.00
CG.TO balance_sheet (annual, 2024-12-31) — Receivables: 117679000.00
CG.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 836455000.00
CG.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 130662000.00
CG.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -9790000.00
CG.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -44053000.00
CG.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: 808270000.00
CG.TO income_statement (annual, 2024-12-31) — Salaries And Wages: 5203000.00
CG.TO cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
CG.TO cash_flow (annual, 2024-12-31) — Sale Of PPE: 959000.00
CG.TO cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 84000.00
CG.TO income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 10683000.00
CG.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 48571000.00
CG.TO balance_sheet (annual, 2024-12-31) — Share Issued: 210031280.00
CG.TO income_statement (annual, 2024-12-31) — Special Income Charges: -129873000.00
CG.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 5203000.00
CG.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1655916000.00
CG.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 1655916000.00
CG.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -12849900.00
CG.TO income_statement (annual, 2024-12-31) — Tax Provision: 93663000.00
CG.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.15
CG.TO balance_sheet (annual, 2024-12-31) — Taxes Receivable: 2274000.00
CG.TO balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 2274000.00
CG.TO cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -109109000.00
CG.TO balance_sheet (annual, 2024-12-31) — Total Assets: 2265133000.00
CG.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 1655916000.00
CG.TO balance_sheet (annual, 2024-12-31) — Total Debt: 20106000.00
CG.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1655916000.00
CG.TO income_statement (annual, 2024-12-31) — Total Expenses: 978214000.00
CG.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 609217000.00
CG.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1272071000.00
CG.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 325337000.00
CG.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 76517000.00
CG.TO income_statement (annual, 2024-12-31) — Total Other Finance Cost: 3282000.00
CG.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 18731000.00
CG.TO income_statement (annual, 2024-12-31) — Total Unusual Items: -85666000.00
CG.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -85666000.00
CG.TO cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -23500000.00
CG.TO balance_sheet (annual, 2024-12-31) — Working Capital: 709182000.00
CG.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 32237000.00
CG.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 299499000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 238019000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 110457000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 31810000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 74815000.00
CG.TO income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: -1743000.00
CG.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 209329000.00
CG.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.15
CG.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 624673000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 705781000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -48567000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 19510000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 814030000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 608174000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 611900000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -10266000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -26543000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -48567000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 58611000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: 9171000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 1217000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 5938000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -37208000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -20882000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -16499000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 814030000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -10266000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1660423000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 859000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -14919000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 112649000.00
CG.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 222962000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 1007399000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 6313000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 6313000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 314672000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Current Provisions: 3528000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 24824000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: 24824000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 24868000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 4502000.00
CG.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 213724000.00
CG.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.13
CG.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 28711000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 47231000.00
CG.TO income_statement (quarterly, 2025-03-31) — EBIT: 59148000.00
CG.TO income_statement (quarterly, 2025-03-31) — EBITDA: 84016000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 1716000.00
CG.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 608174000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Financial Assets: 22544000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -26543000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 10044000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: -6630000.00
CG.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Business: 6630000.00
CG.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 2657000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -13875000.00
CG.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 10307000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1143697000.00
CG.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 76537000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 1591000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 45673000.00
CG.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 3870000.00
CG.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 3870000.00
CG.TO income_statement (quarterly, 2025-03-31) — Interest Income: 5371000.00
CG.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 5371000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 223565000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1660423000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -48567000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 74815000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 74815000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 859000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 13197000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 13197000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -2217000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 290480000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -14060000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -3106000.00
CG.TO income_statement (quarterly, 2025-03-31) — Net Income: 30454000.00
CG.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 30454000.00
CG.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 30454000.00
CG.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 30454000.00
CG.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 30454000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 30454000.00
CG.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 30454000.00
CG.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: 1501000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
CG.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -2217000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -2217000.00
CG.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 1501000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 1143697000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -48567000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1660423000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 10291000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 49620000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 24471000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 20471000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 49620000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4000000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1716000.00
CG.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 74729000.00
CG.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 22560050.00
CG.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 58611000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -9736000.00
CG.TO income_statement (quarterly, 2025-03-31) — Operating Income: 44300000.00
CG.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 276460000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 207944128.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 553000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 21139000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -13875000.00
CG.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 9481000.00
CG.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 9477000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 8306000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1095000.00
CG.TO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 190000.00
CG.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 13099000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 55711000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 3726000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Payables: 283692000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 283692000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 12102000.00
CG.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 55278000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
CG.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -48567000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 157688000.00
CG.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 222962000.00
CG.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 24868000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -2217000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -14919000.00
CG.TO income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 828458000.00
CG.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 826000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
CG.TO income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 2802000.00
CG.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 13109000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 207944128.00
CG.TO income_statement (quarterly, 2025-03-31) — Special Income Charges: 6630000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 826000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1660423000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1660423000.00
CG.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 1393050.00
CG.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 24824000.00
CG.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
CG.TO cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -1449000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 2309461000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1660423000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 19510000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1660423000.00
CG.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 255199000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 649038000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1302062000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 334366000.00
CG.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 42900000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 45673000.00
CG.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 9287000.00
CG.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 9287000.00
CG.TO cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 1400000.00
CG.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 692727000.00
CG.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 18853000.00
CG.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 288343000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 250463000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 123483000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 32214000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 93732000.00
CG.TO income_statement (quarterly, 2025-06-30) — Average Dilution Earnings: -1852000.00
CG.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 206080000.00
CG.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.33
CG.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 608174000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 700258000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -50883000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 19557000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 782408000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 522340000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 522340000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -10582000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -38524000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -72615000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 25305000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: -15617000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -11130000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 6677000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -5684000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -25754000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -85834000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 782408000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -10582000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1703725000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 1387000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -27032000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 144700000.00
CG.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 200905000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 967214000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 6444000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 6444000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 279687000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Current Provisions: 1467000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -2155000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: -2155000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 26876000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 3757000.00
CG.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 210448000.00
CG.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.32
CG.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 66721000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 59145000.00
CG.TO income_statement (quarterly, 2025-06-30) — EBIT: 70502000.00
CG.TO income_statement (quarterly, 2025-06-30) — EBITDA: 97378000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 1877000.00
CG.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 522340000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Financial Assets: 25550000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -38524000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -25578000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of Business: -14977000.00
CG.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: 14977000.00
CG.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 245000.00
CG.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -17704000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 2653000.00
CG.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 9709000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1167322000.00
CG.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 87438000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 7027000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 4518000.00
CG.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 4084000.00
CG.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 4084000.00
CG.TO income_statement (quarterly, 2025-06-30) — Interest Income: 5701000.00
CG.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 5701000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 241680000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1703725000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -72615000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 93732000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 93732000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 1387000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 13113000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 13113000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -2297000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 288948000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -25645000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 12411000.00
CG.TO income_statement (quarterly, 2025-06-30) — Net Income: 68573000.00
CG.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 68573000.00
CG.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 68573000.00
CG.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 68573000.00
CG.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 68573000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 68573000.00
CG.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 68573000.00
CG.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: 1617000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -21977000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -2297000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -2297000.00
CG.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 1617000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 1167322000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -50638000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1703725000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 10283000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 52080000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 25083000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 20764000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 52080000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 4319000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 1877000.00
CG.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 99860000.00
CG.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 70682700.00
CG.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 25305000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -2566000.00
CG.TO income_statement (quarterly, 2025-06-30) — Operating Income: 68585000.00
CG.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 282267000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 204325992.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 770000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 16795000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 2653000.00
CG.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 7664000.00
CG.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: -3784000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -6432000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1132000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 1123000.00
CG.TO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -1302000.00
CG.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 2845000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 322364000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Payables: 254981000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 254981000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 12769000.00
CG.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 66418000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -21977000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -50883000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 182628000.00
CG.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 200905000.00
CG.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 26876000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -2297000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -27032000.00
CG.TO income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 0.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 886450000.00
CG.TO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 2045000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 245000.00
CG.TO income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 2698000.00
CG.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 12407000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 204325992.00
CG.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: 15222000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 2045000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1703725000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1703725000.00
CG.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -372300.00
CG.TO income_statement (quarterly, 2025-06-30) — Tax Provision: -2155000.00
CG.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
CG.TO cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -47382000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 2317313000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1703725000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 19557000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1703725000.00
CG.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 219758000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 613588000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1350099000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 333901000.00
CG.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 56485000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 4518000.00
CG.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -2482000.00
CG.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -2482000.00
CG.TO cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 12100000.00
CG.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 687527000.00
CG.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 44456000.00
CG.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 395163000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 319809000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 115026000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 32837000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: -193520000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 181777000.00
CG.TO income_statement (quarterly, 2025-09-30) — Average Dilution Earnings: 1991000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 522340000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 697202000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -63011000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 17622000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 766776000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 561796000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 568228000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -10278000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -34378000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -87819000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 161653000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 66105000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: -3892000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Change In Inventory: -43737000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 47202000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: 62213000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 62213000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -38286000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: -3892000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 27392000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 39456000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 766776000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -10278000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1939452000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 684000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -22050000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 183007000.00
CG.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 258731000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 1070974000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 6156000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 6156000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 370810000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Current Provisions: 473000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 59581000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: 59581000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 36095000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 45416000.00
CG.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 294179000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 30377000.00
CG.TO income_statement (quarterly, 2025-09-30) — EBIT: 354757000.00
CG.TO income_statement (quarterly, 2025-09-30) — EBITDA: 390852000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 2221000.00
CG.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 561796000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Financial Assets: 29653000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -34378000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 98642000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: -16264000.00
CG.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: 16264000.00
CG.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: -19000.00
CG.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 48187000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -28521000.00
CG.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 15029000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1369713000.00
CG.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 136432000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 3112000.00
CG.TO income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: -193520000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 23368000.00
CG.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 2988000.00
CG.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 2988000.00
CG.TO income_statement (quarterly, 2025-09-30) — Interest Income: 5252000.00
CG.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 5252000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Cff: -505000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 293821000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1939452000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -87819000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 181777000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 181777000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 684000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 11466000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 11466000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -2229000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 284028000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -21366000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -5520000.00
CG.TO income_statement (quarterly, 2025-09-30) — Net Income: 292188000.00
CG.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 292188000.00
CG.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 292188000.00
CG.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 292188000.00
CG.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 292188000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 292188000.00
CG.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 292188000.00
CG.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: 2264000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -24857000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -2229000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -2229000.00
CG.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 2264000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 1369713000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -62962000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1939452000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 5989000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 29515000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 34291000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 24191000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 29515000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 10100000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 2221000.00
CG.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 132900000.00
CG.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 77926712.12